Lipoprotein metabolism abnormalities in patients with chronic renal insufficiency

Journal of Medical Biochemistry

Volumn 30, Issue 1, 2011, Pages 38-44

  Ali, Abdellah ^a   Sultan, Phalisteen ^b   El Napoli, Mohamed ^a   Fahmy, Mohamed ^c  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Omar Al Mukhtar University   (Libyan Arab Jamahiriya)

^c AL AZHAR UNIVERSITY   (Egypt)

Author keywords

chronic renal disease; hemodialysis; lipoprotein

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; REVERSE CHOLESTEROL TRANSPORT; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78649667362     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0040-9     Document Type: Article

References (32)

1. Ma KW, Green EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19: 505-13.
2. Jungers P, Massy ZA, Nguzen Khoa T, Fumeron C, Labrunie M, Lacour B. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-602.
3. Herzog CA. Acute myocardial infarction in patients with end-stage renal disease. Kidney Int 1999; 56 (71 Suppl): 130S-133S.
4. Mittman N, Avram MM. Dyslipidemia in renal disease. Seminars in Nephrology 1996; 16: 202-13.
5. Koniger MK, Quaschning T, Wanner C, Schollmeyer P, Kramer-Guth A. Abnormalities in lipoprotein meta bolism in hemodialysis patients. Kidney Int 1999; 56 (71 Suppl): 248S-250S.
6. Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J. Lipoprotein abnormalities in hyper lipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 1992; 41: 1394-9.
7. O'Neal D, Lee P, Murphy B, Best J. Low density lipo protein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis 1996; 27: 84-91.
8. Rajman I, Harper L, McPake D, Kendall MJ, Wheeler D. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant 1998; 13: 2281-7.
9. Arnadottir M. Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase. Scand J Clin Invest 1997; 57: 1-11.
10. Chan MK, Persaud J, Varghese Z, Moorhead J F. Pathogenic role of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 1984; 25: 812-8.
11. Murase T, Cattran DC, Rubinstein B, Steiner G. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 1975; 24: 1279-186.
12. Persson E, Nordstrom J, Nilsson-Ehle P. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment. Scand J Clin Invest 1987; 47: 151-5.
13. Wakabayshi Y, Okubo M, Shimada H, Sato N, Koide A, Marumo F. Decreased VLDL apolipoprotein CII/apo lipo protein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment. Metabolism 1987; 36: 815-20.
14. Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA. Carbamylation-induced alterations in low-density lipopro tein metabolism. Kidney Int 1992; 41: 1175-81.
15. Bucal R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A. Modification of LDL by advanced glycosylation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994; 91: 9441-5.
16. Hokko S, Huttunen K, Korhonen T, Kesaniemi YA. Decreased clearance of low density lipoprotein in patients with chronic renal failure. Kidney Int 1994; 45: 561-70.
17. Shoji T, Nishizava Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 1992; 41: 1653-61.
18. Vaziri ND, Deng G, Liang K. Hepatic HDL receptor, SR'B1 and apo AI expression in chronic renal failure. Nephrol Dial Transplant 1999; 14: 1462-6.
19. Massy ZA, Nguyen Khoa T, Lacour B, Descamps-Latscha B, Man NK, Jungers P. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 1999; 14: 2392-7.
20. Attman PO, Alaupovic P, Samuelsson P. Lipoprotein abnor malities as a risk factor for progressive nondiabetic renal disease. Kidney Int 1999; 56 (71 Suppl): 14S-17S.
21. Attman PO, Samuelsson P, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993; 21: 373-92.
22. Moorhead J F, El-Nahas M, Chan MK, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; 11: 1309-11.
23. Keane W F. Lipids and kidney. Kidney Int 1994; 46: 910-20.
24. Derić M, Čabarkapa V. Cardiovascular biomarkers in chronic kidney diseases. Journal of Medical Biochemistry 2010; 29: 298-303.
25. Sperschneider H, Deppisch R, Beck W, Wolf H, Stein G. Impact of membrane choice and blood flow pattern on coagulation and heparin requirement potential conseq uences on lipid concentrations. Nephrol Dial Transplant 1997; 12: 3638-46.
26. Schmitt Y, Schaeider H. Low-molecular-weight heparin (LMWH)): influence on blood lipids in patients on chronic hemodialysis. Nephrol Dial Transplant 1993; 8: 438-42.
27. Lacour B, Roullet JB, Beyne P. Comparison of several atherogenicity indices by analysis of serum lipoprotein composition in patients with chronic renal failure with or without hemodialysis, and in renal transplant patients. J Clin Chem Biochem 1985; 23: 805-10.
28. Ot K, Hirano T, Sakai S, Kawaguchi Y, Hosoya T. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemo dialysis patients. Kidney Int 1999; 56 (71 Suppl): 227S-8S.
29. Galle J, Heermeier K, Wanner C. Atherogenic lipoproteins, oxidative stress and cell death. Kidney Int 1999; 56 (71 Suppl): 62S-65S.
30. Ma KW, Green EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19: 505-13.
31. Gardner CD, Fortmann S P, Krauss RM. Association of small low density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875-81.
32. Rajman I, Kendall MJ, Cramb R, Holder RI, Salih M, Gammaage MD. Investigation of the low density lipoprotein subfractions profile as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996; 125: 231-242.